Potassium Phosphate, Tribasic → HCID 56943054, 화합물

HRID 1843978

반응식

HRID 1843978 반응식
[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][C:11]=1[Cl:12])[C:8](=[O:13])[NH:7][CH2:6][CH2:5]2.Br[C:15]1[CH:16]=[N:17][CH:18]=[CH:19][C:20]=1[C:21]([F:24])([F:23])[F:22].P([O-])([O-])([O-])=O.[K+].[K+].[K+]>[Cu](I)I.O1CCOCC1>[Cl:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][C:11]=1[Cl:12])[C:8](=[O:13])[N:7]([C:15]1[CH:16]=[N:17][CH:18]=[CH:19][C:20]=1[C:21]([F:24])([F:23])[F:22])[CH2:6][CH2:5]2

참가 물질

6

반응물 3

HCID 62657Potassium Phosphate, TribasicHCID 141771016,7-Dichloro-3,4-dihydro-2H-isoquinolin-1-oneHCID 199372633-Bromo-4-(trifluoromethyl)pyridine

생성물 1

HCID 56943054HCID 56943054, 화합물수율 8.4%

시약·촉매·용매 2

HCID 83717Copper iodide촉매HCID 312751,4-Dioxane용매

실험 절차

Using an analogous procedure and workup as described for the preparation of Example 1A above, 6,7-dichloro-3,4-dihydroisoquinolin-1(2H)-one (I-55d: 100 mg, 0.463 mmol) was reacted with 3-bromo-4-(trifluoromethyl)pyridine (115 mg, 0.509 mmol), 1,4-dioxane (3 mL), copper iodide (7 mg, 0.046 mmol), trans-N,N′-dimethyl-cyclohexyl-1,2-diamine (20 mg, 0.1388 mmol) and potassium phosphate (245 mg, 1.157 mmol) in a sealed tube at 120° C. for 16 hours to afford the crude product. Purification by column chromatography on silica gel (20% ethylacetate in hexane) afforded 14 mg of the product (8.3% yield).

후처리

  1. customto afford the crude product
  2. customPurification by column chromatography on silica gel (20% ethylacetate in hexane)

출처 및 근거

ORD 기록
ord-0b202715be644a648d4a135f342adfd8
출처 데이터셋
uspto-grants-2015_02
특허 번호
US08946260B2

연결된 노트

불러오는 중…